iBio (IBIO) Cash from Financing Activities (2009 - 2026)
iBio (IBIO) recorded Cash from Financing Activities of $19.4 million in fiscal Q4 2026 (quarter ended Jun 30, 2026), up 137.2% from $8.18 million a year earlier but down 31.1% from the prior quarter.
Powered by 
Analysis
iBio (IBIO) Cash from Financing Activities (2009 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), iBio reported Cash from Financing Activities of $103.05 million.
- Annual Cash from Financing Activities has a five-year compound annual growth rate of 5.5% (FY2021 to FY2026).
- Across earlier fiscal years, Cash from Financing Activities came in at $8.93 million in FY2025 (-63.5%), $24.49 million in FY2024 (+964.5%), $2.3 million in FY2023 and -$6.13 million in FY2022.
- Quarterly Cash from Financing Activities has ranged from -$6.02 million in fiscal Q2 2022 to $46.71 million in fiscal Q1 2026 over the past five years.
- Per Business Quant, the preceding three fiscal quarters came in at $28.15 million (Q3 2026), $8.79 million (Q2 2026) and $46.71 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -7.22 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -8.53 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 6.82 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | -2.43 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 6.63 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | -4.39 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -1.53 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | -2.51 Bn |
| 10 | iBio | 118.23 Mn | -174.02 Mn | - | -1.12 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -1.12 Mn |
| Jun 30, 2026 | 19.40 Mn |
| Mar 31, 2026 | 28.15 Mn |
| Dec 31, 2025 | 8.79 Mn |
| Sep 30, 2025 | 46.71 Mn |
| Jun 30, 2025 | 8.18 Mn |
| Mar 31, 2025 | 1.06 Mn |
| Dec 31, 2024 | -152,000.00 |
| Sep 30, 2024 | -162,000.00 |
| Jun 30, 2024 | 12.99 Mn |
| Mar 31, 2024 | 5.03 Mn |
| Dec 31, 2023 | 4.01 Mn |
| Sep 30, 2023 | 2.47 Mn |
| Jun 30, 2023 | 2.74 Mn |
| Mar 31, 2023 | 1.46 Mn |
| Dec 31, 2022 | -3.04 Mn |
| Sep 30, 2022 | 1.14 Mn |
| Jun 30, 2022 | -10,000.00 |
| Mar 31, 2022 | -10,000.00 |
| Dec 31, 2021 | -6.02 Mn |
API Access
iBio Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=IBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "IBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=IBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();